Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
May 16, 2025
Vaccines Weekly Update – May 16th 2025
May 16, 2025
Public Health Weekly News – May 16th 2025
May 15, 2025
Cardiovascular Weekly News – May 15th 2025
May 15, 2025
Cell and Gene Therapy Weekly News – May 15th 2025
May 15, 2025
Rare Diseases Weekly News – May 15th 2025
May 14, 2025
Neuroscience Weekly News – May 14th 2025
May 14, 2025
Women’s Health Weekly News – May 14th 2025
May 14, 2025
Immunology Weekly News – May 14th 2025
May 13, 2025
ASGCT 2025 Preview
May 13, 2025
Obesity Weekly News – May 13th 2025
May 13, 2025
ASGCT 2025 PREVIEW: Key Cell and Gene Therapy Highlights to Watch
May 13, 2025